Cargando…
Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine”
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817758/ https://www.ncbi.nlm.nih.gov/pubmed/36621252 http://dx.doi.org/10.1016/j.eimce.2022.07.008 |
_version_ | 1784864821804531712 |
---|---|
author | Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj |
author_facet | Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj |
author_sort | Mungmunpuntipantip, Rujittika |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9817758 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98177582023-01-06 Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine” Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Enferm Infecc Microbiol Clin (Engl Ed) Letter to the Editor Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. 2023-01 2023-01-06 /pmc/articles/PMC9817758/ /pubmed/36621252 http://dx.doi.org/10.1016/j.eimce.2022.07.008 Text en © 2022 Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Mungmunpuntipantip, Rujittika Wiwanitkit, Viroj Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine” |
title | Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine” |
title_full | Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine” |
title_fullStr | Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine” |
title_full_unstemmed | Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine” |
title_short | Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine” |
title_sort | comment on “tachycardia following pfizer-biontech covid-19 vaccine” |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817758/ https://www.ncbi.nlm.nih.gov/pubmed/36621252 http://dx.doi.org/10.1016/j.eimce.2022.07.008 |
work_keys_str_mv | AT mungmunpuntipantiprujittika commentontachycardiafollowingpfizerbiontechcovid19vaccine AT wiwanitkitviroj commentontachycardiafollowingpfizerbiontechcovid19vaccine |